FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma

FDA oncologists discuss the approval of avelumab for the treatment of patients 12 years and older with metastatic Merkel cell carcinoma.

ReachMD Healthcare Image
Media formats available
  • Completing the pre-test is required to access this content.
    Pre-Survey
    Completing the pre-survey is required to access this content.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free